Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9487556

    Polyconjugates for delivery of RNAi triggers to tumor cells in vivo

    Arrowhead Pharmaceuticals, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 9487563

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 9487551

    Small molecule compounds that control mammal-pathogenic nematodes

    The Regents of the University of California · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 9486426

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 9487500

    Compounds and compositions thereof

    Inhibikase Therapeutics, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 9487485

    Method for producing sulfonyl chloride compound

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9486518

    Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 9487522

    SSH-2 (slingshot-2) inhibitors and methods for making and using them

    The Regents of the University of California · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 9487509

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 9487508

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 9487511

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 9487493

    Use of a PPAR-delta agonist for treating muscle atrophy

    VTV THERAPEUTICS LLC · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 9486539

    Nipah virus envelope pseudotyped lentiviruses and methods of their use

    The Regents of the University of California · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 9486457

    Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders

    The Regents of the University of California · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 9486414

    Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 9486401

    Use of cellular extracts for skin rejuvenation

    REGENICS AS · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 9487473

    Oligomer-amino acid conjugates

    Nektar Therapeutics · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 9486451

    Abuse resistant pharmaceutical compositions

    RECRO GAINESVILLE LLC · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 9486456

    Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof

    The Board of Regents of the University of Texas System · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 9486446

    Orally disintegrating solid preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 9486424

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 9486481

    Method of modulating fatty acid mobilization and oxidation

    Reoxcyn Discoveries Group, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 9486489

    Method for producing dry extracts

    BIONORICA SE · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 9487753

    Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease

    DiscGenics, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 9487780

    Antisense compounds targeting genes associated with fibronectin

    Ionis Pharmaceuticals, Inc. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 2016324873

    Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or its 9,11-Dehydroderivatives

    CASSIOPEA S P A [IT] · Granted Thu Nov 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 9493482

    Compounds and methods for preventing or treating sensory hair cell death

    Oricula Therapeutics LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 9491934

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 9492378

    Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 9492439

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 9492415

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 9492430

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 9492433

    Pharmaceutical composition for the treatment of Duchenne muscular dystrophy

    Summit Corporation Plc · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 9492443

    Abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 9492452

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 9492477

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 9492490

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 9492484

    Cardiosphere derived cell population and methods of use

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 9493626

    Dispersions comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 9492520

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 9492523

    Broadly protective Shigella vaccine based on type III secretion apparatus proteins

    The Board of Regents for Oklahoma State University · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 9492781

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 9493738

    Method for producing high yield attenuated Salmonella strains

    Vaximm AG · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 9492569

    Antibodies that bind integrin alpha-V beta-8

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 9493429

    Substituted benzoxazoles and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 9493484

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 9493467

    PI3 kinase antagonists

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 9493526

    Compositions and methods for the delivery of oxygen

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.